Skip to main content
  • Home
  • News
  • MAA MYASTHENIA GRAVIS CONFERENCE 2019 - PROGRAMME OVERVIEW

MAA MYASTHENIA GRAVIS CONFERENCE 2019 - PROGRAMME OVERVIEW

MAA MYASTHENIA GRAVIS CONFERENCE 2019 - PROGRAMME OVERVIEW

Posted on Friday, July 05 2019

Welcome - Mrs Susan White MAA President, Mrs Carol Buchanan Conference MC

Dr Stefan Blum - “Overview of Myasthenia Gravis and its Therapies”

Dr James Morton - “Plasma Exchange and Other Advanced Therapies for Myasthenia Gravis”

Dr David McEniery - “Update on Myasthenia Gravis Survey”

Prof. Pam McCombe - “IVIg for Myasthenia - New IVIg Guidelines”

Dr Fiona Chan - “Rituximab as Treatment of Myasthenia Gravis”

Assoc. Prof. Stephen Reddel - “Problems with Myasthenia Gravis Therapy”

“MG and its Treatment - Questions and Panel Discussion” - Dr James Morton, Assoc. Prof. Stephen Reddel, Prof. Pam McCombe, Dr Fiona Chan, Dr Stefan Blum 

Nicole Millis - “Advocacy and Rare Disease”

Assoc. Prof. Stephen Reddel - “Rationale and Progress on eNID Project”

“Research in MG - Questions and Discussion”- Dr Andrew Swayne, Assoc. Prof. Stephen Reddel, Dr Stefan Blum

“Break-Out Session 1” Choose from 5 sessions – subject to space availability.

Dr Andrew Swayne - “Research in Myasthenia Gravis – Where Are We, Where Do We Need To Go?”

“Break-Out Session 2” Choose from 6 sessions – subject to space availability.

Note: Programme Schedule is subject to change.

MessaGes Mailing List

Enter your details below to receive our monthly MessaGes Newsletter and upcoming News and Events directly to your Email inbox.